You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 19, 2024

~ Buy the DAYVIGO (lemborexant) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR DAYVIGO

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for DAYVIGO

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT04555733 ↗	A Single and Multiple Dose Study of Lemborexant in Healthy Chinese Participants	Completed	Eisai Co., Ltd.	Phase 1	2020-10-26	The primary objective of this study is to assess the pharmacokinetics (PK) of lemborexant and metabolites (M4, M9, and M10) in plasma in healthy Chinese participants following single and multiple oral doses of lemborexant.
NCT04818086 ↗	Drug-drug Interaction Study of Lemborexant as an Adjunctive Treatment for Buprenorphine/Naloxone for Opioid Use Disorder	Recruiting	National Institute on Drug Abuse (NIDA)	Phase 1/Phase 2	2021-05-03	The purpose of this research study is to test the safety, tolerability, drug interactions with buprenorphine-naloxone, and effectiveness lemborexant when used to treat Opioid Use Disorder.
NCT04818086 ↗	Drug-drug Interaction Study of Lemborexant as an Adjunctive Treatment for Buprenorphine/Naloxone for Opioid Use Disorder	Recruiting	Virginia Commonwealth University	Phase 1/Phase 2	2021-05-03	The purpose of this research study is to test the safety, tolerability, drug interactions with buprenorphine-naloxone, and effectiveness lemborexant when used to treat Opioid Use Disorder.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for DAYVIGO

Condition Name

Chart
Table

Condition Name for DAYVIGO
Intervention	Trials
Sleep Initiation and Maintenance Disorders	1
Alcohol Use Disorder	1
Alzheimer Disease	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for DAYVIGO
Intervention	Trials
Alcoholism	1
Parasomnias	1
Dyssomnias	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for DAYVIGO

Trials by Country

Map
Table

Trials by Country for DAYVIGO
Location	Trials
United States	5
China	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for DAYVIGO
Location	Trials
Missouri	1
Texas	1
California	1
Nevada	1
Virginia	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for DAYVIGO

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for DAYVIGO
Clinical Trial Phase	Trials
Phase 4	1
Phase 3	1
Phase 2	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for DAYVIGO
Clinical Trial Phase	Trials
Not yet recruiting	3
Recruiting	2
Completed	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for DAYVIGO

Sponsor Name

Chart
Table

Sponsor Name for DAYVIGO
Sponsor	Trials
Eisai Co., Ltd.	2
Eisai Inc.	2
Baylor College of Medicine	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for DAYVIGO
Sponsor	Trials
Other	4
Industry	4
NIH	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.